A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).

Clinical trial NCT01563328 · COMPLETED

Trial details

NCT number: NCT01563328
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus

Start date: 2012-03-01
Primary completion: 2012-05-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.